Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

31 May, 2025 | Saturday

Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

19 May 2025 | Monday | Interview

From vaccine awareness to cancer care, Docquity’s tailored PSP solutions and regional insights are transforming access, affordability, and adherence through strategic partnerships with pharma leaders like AstraZeneca.

In this interview with BioPharma APAC, Christophe Meugnier, Chief Commercial Officer and General Manager of Vietnam & Thailand at Docquity, discusses how the company’s patient support arm, DocquityCare, is helping transform healthcare delivery across Southeast Asia. Through data-driven strategies, localized content, and multichannel engagement, Docquity is addressing barriers to treatment and building impactful collaborations in cancer care, rare diseases, and vaccine education.

How does Docquity support partners such as AstraZeneca in shaping their patient educational content and outreach strategy?

As Southeast Asia’s largest network of verified healthcare professionals (HCPs), we’re uniquely positioned to help partners such as AstraZeneca address regional healthcare challenges through greater patient support. DocquityCare, our digitized patient solutions business, leverages our in-depth industry insights and robust technology platform to develop secure, data-driven engagement strategies that help improve patient awareness, adherence, and affordability. Our multidisciplinary teams, including HCPs, educators, content creators, and technology developers, work closely with partners to develop locally relevant programs that reach more patients. This leads to tangible impact, including earlier diagnoses, higher enrollment in support programs, increased access to medications, and streamlined healthcare delivery, all of which drive significant healthcare savings and outcomes.

Given that only 46.1% of regional doctors currently have patients enrolled in PSPs, what barriers remain in expanding patient participation, and how is Docquity addressing these challenges?

Our latest Docquity Pulse Check report on vaccine hesitancy in Southeast Asia revealed that while 85.7% of doctors believe patient support programs (PSPs) can improve vaccine uptake, only 46.1% currently have patients enrolled in PSPs in general. In the study of regional immunization rates, low patient awareness around vaccine benefits emerged as the top barrier, cited by 83.9% of doctors. Digital technology provides us with a profound opportunity to address this gap across healthcare challenges, democratizing education, access and support for more patients in need.

DocquityCare therefore combines digital platforms, social media, and call center outreach to deliver timely and trusted information to a greater number of patients. It drives programs such as OAZisCare, our recent partnership with AstraZeneca, which improves cancer care and enhanced respiratory syncytial virus (RSV) vaccine education and adherence in Thailand. Through our insights-driven approach to reach patients and their caregivers across channels, OAZisCare has provided educational resources to tens of thousands in just a year and enrolled eligible patients into its adherence program.

Similarly, DocquityCare’s 2021 pilot in the Philippines enabled over 350 doctors from 150 hospitals to support more than 1,000 patients with cancer, increasing access to needed medicines at affordable rates and delivering over US$1M in total patient savings.

How does DocquityCare customize its digital solutions to accommodate cultural and linguistic differences across Southeast Asian countries?

Tackling healthcare issues across markets requires meaningful localization, especially in a region as diverse as Southeast Asia. That’s why we tailor every DocquityCare initiative to reflect the language, culture, and platforms patients trust. In Thailand, for example, our partnership with AstraZeneca leverages digital platforms and LINE to deliver OAZisCare content in Thai. From articles and videos to podcasts, all materials have been designed to address local needs in cancer care and RSV vaccine education, ensuring optimal relevance.

What are the next therapeutic areas or diseases that Docquity plans to target or similar PSP collaborations in Southeast Asia?

Since piloting in the Philippines in 2021, DocquityCare now powers 18 patient programs across the region. As we expand across Southeast Asia, we’re deepening our focus on critical areas such as cancer care, rare diseases, vaccine-preventable diseases, and low-adherence medications. In partnership with pharmaceutical companies and other healthcare organizations, we aim to transform healthcare delivery and break down barriers to essential life-changing treatments.

With digital health platforms expanding rapidly, how does Docquity ensure data privacy and regulatory compliance across diverse Southeast Asian markets?

Security is foundational. We follow a ‘Privacy-by-Design’ approach and comply with national laws across Southeast Asia, alongside global standards like GDPR. Our systems are continuously updated to stay ahead of threats and ensure we meet both local and international regulatory standards that protect patient privacy and partner trust.

Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

Stay Connected